Rybelsus (semaglutide) 7mg is an innovative oral medication used to improve blood sugar control in adults with type 2 diabetes. Manufactured by Novo Nordisk, it is the first tablet form of the GLP-1 receptor agonist class, offering a convenient alternative to injectable treatments like Ozempic.
Key Benefits
- Effective Glycemic Control: Helps lower HbA1c levels by stimulating insulin secretion and reducing glucagon release.
- Convenient Oral Dose: Eliminates the need for weekly injections.
- Weight Management Support: Many users experience weight loss as a secondary benefit while managing their blood sugar.
How to Take Rybelsus 7mg
To ensure maximum absorption, you must take Rybelsus exactly as prescribed:
- Take it first thing in the morning on an empty stomach.
- Swallow the tablet whole with a small sip of plain water (no more than 120ml).
- Wait at least 30 minutes before eating, drinking anything else, or taking other oral medications.
Precautions & Side Effects
Rybelsus is a prescription-only medication (POM). Common side effects include nausea, stomach pain, and diarrhea, which typically decrease over time. It is important to consult a GoMed pharmacist or your doctor to discuss if this medication is right for you, especially regarding its use during pregnancy or if you have a history of thyroid issues. Store the tablets in their original blister pack until use to protect them from moisture.